A detailed history of Franklin Resources Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Franklin Resources Inc holds 875,842 shares of NVO stock, worth $74.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
875,842
Previous 875,842 -0.0%
Holding current value
$74.4 Million
Previous $104 Million -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $524,503 - $640,575
-4,405 Reduced 0.5%
875,842 $104 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $31.9 Million - $38.2 Million
260,279 Added 41.98%
880,247 $126 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $7.64 Million - $10.2 Million
74,850 Added 13.73%
619,968 $79.6 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $203,649 - $244,644
-2,320 Reduced 0.42%
545,118 $56.4 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $23.3 Million - $51.1 Million
255,979 Added 87.83%
547,438 $49.8 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $2.89 Million - $3.19 Million
-18,500 Reduced 5.97%
291,459 $47.2 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $1.62 Million - $1.95 Million
-12,235 Reduced 3.8%
309,959 $49.3 Million
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $271,347 - $358,083
-2,646 Reduced 0.81%
322,194 $43.6 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $155,401 - $190,712
-1,631 Reduced 0.5%
324,840 $32.4 Million
Q2 2022

Aug 11, 2022

SELL
$103.24 - $121.81 $1.7 Million - $2 Million
-16,426 Reduced 4.79%
326,471 $36.4 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $934,165 - $1.13 Million
-10,034 Reduced 2.84%
342,897 $38.1 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $365,111 - $445,840
-3,808 Reduced 1.07%
352,931 $39.5 Million
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $685,659 - $865,967
-8,122 Reduced 2.23%
356,739 $34.3 Million
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $1.18 Million - $1.47 Million
-17,374 Reduced 4.55%
364,861 $30.6 Million
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $1.06 Million - $1.19 Million
15,733 Added 4.29%
382,235 $25.8 Million
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $9.53 Million - $11 Million
149,197 Added 68.66%
366,502 $25.6 Million
Q3 2020

Nov 12, 2020

SELL
$63.69 - $70.22 $4.09 Million - $4.51 Million
-64,164 Reduced 22.8%
217,305 $15.1 Million
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $1.13 Million - $1.31 Million
-19,321 Reduced 6.42%
281,469 $19.3 Million
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $415,958 - $544,799
-8,410 Reduced 2.72%
300,790 $18.1 Million
Q4 2019

Feb 12, 2020

SELL
$49.86 - $58.26 $1.52 Million - $1.78 Million
-30,585 Reduced 9.0%
309,200 $17.9 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $1.84 Million - $2.06 Million
-38,628 Reduced 10.21%
339,785 $17.6 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $1.69 Million - $1.89 Million
-36,042 Reduced 8.7%
378,413 $19.3 Million
Q1 2019

May 14, 2019

SELL
$46.36 - $52.63 $2.17 Million - $2.46 Million
-46,713 Reduced 10.13%
414,455 $21.7 Million
Q4 2018

Feb 12, 2019

SELL
$41.54 - $47.25 $729,317 - $829,568
-17,557 Reduced 3.67%
461,168 $21.2 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $480,271 - $526,286
-10,271 Reduced 2.1%
478,725 $22.6 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $1.97 Million - $2.25 Million
-44,570 Reduced 8.35%
488,996 $22.6 Million
Q1 2018

May 10, 2018

SELL
$48.49 - $58.14 $2.5 Million - $2.99 Million
-51,460 Reduced 8.8%
533,566 $26.3 Million
Q4 2017

Feb 14, 2018

SELL
$47.53 - $53.73 $3.39 Million - $3.84 Million
-71,420 Reduced 10.88%
585,026 $31.4 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $27 Million - $32.3 Million
656,446
656,446 $31.6 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.